P @ Work

Progress at Work - The Impact of an Active Drug on Work Related Productivity in Patients With Rheumatoid Arthritis

Brief summary

The purpose of this study is to describe the impact of treatment with an active drug on work related productivity and economic burden in patients with Rheumatoid Arthritis (RA) treated in Canada.

Observational study

Status:
Completed
Conditions:
Rheumatoid Arthritis
Enrollment:
401 patients
Protocol ID:
P14-455
Observational model:
Cohort
Time perspective:
Prospective

 

Eligibility criteria

Participant attributes:
Male and Female

Age:

From 18 Years to 99 Years.

Inclusion Criteria:

1. Subjects with moderate to severe RA for whom the physician has decided to initiate
treatment with adalimumab

2. Adult male or female ≥ 18 years old that has been newly prescribed adalimumab therapy
according to the local product label and are with PROGRESS

3. Subjects should be evaluated for tuberculosis (TB) exposure/risk factors for active
and latent TB

4. Subject is able to give written patient authorization and is willing to comply with
the requirements of this study protocol.

Exclusion Criteria:

1. Subject cannot or will not sign a patient authorization

2. Subject with a known hypersensitivity to Adalimumab, or any of its components

3. Presence of any condition that, in the opinion of the treating physician, prohibits
the subject from participating in the study or obscures the assessment of the
treatment of RA

4. Subjects currently participating in an investigational clinical trial

5. Subjects treated with >1 prior biologic disease-modifying antirheumatic drugs (DMARDs)
for RA. Any prior treatment with adalimumab is prohibited

6. Subjects previously treated with targeted synthetic disease modifying agent.

All the cities where the clinical studies are located

Cranbrook - V1C 2R7
Penticton - V2A 4Z1
Vancouver - V5Z 1L7
Vancouver - V5Z 3Y1
St. John's - A1B 5E8
St. John's - A1C 5B8
Sydney - B1S 3N1
Barrie - L4M 6L2
Brampton - L6T 0G1
Burlington - L7L 0B7
Dundas - L9H 1B7
Hamilton - L8N 1Y2
Hamilton - L9C 5N2
Mississauga - L5A 1W4
Mississauga - L5A 3V8
Mississauga - L5M 2V8
Niagara Falls - L2E 6A6
Ottawa - K1Y 4G2
Owen Sound - N4K 1S4
Peterborough - K9J 7B3
Toronto - M3H 5S4
Toronto - M9V 4B8
Montreal - H2L 1S6
Montreal - H3T 1E2
Montreal - H3T 1Y3
Montréal - H4N 1C6
Quebec - G1V 4G2
Rimouski - G5L 8W1
Westmount - H3Z 2Z3
Saskatoon - S7K 3H3
Winnipeg - R3A 1M3

More information about this study

clinicaltrials.gov